Published in Medical Letter on the CDC and FDA, April 24th, 2005
"Hypoosmolality produces a dramatic inhibition of vasopressin (VP) and oxytocin gene expression" in the SON, endocrinologists in the United States explained.
In their study, N. Mutsuga and coauthors at the National Institute of Neurological Disorders and Stroke examined "the effect of sustained hypoosmolality on global gene expression in the oxytocin and VP magnocellular neurons of the hypothalamo-neurohypophysial system, to identify genes associated with the magnocellular neuron's adaptation to this physiological condition."
...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.